Watch List: Ferro Corporation, Compania de Minas Buenaventura SA, United States Steel Corporation, Ironwood Pharmaceuticals

Dallas, TX -- (SBWIRE) -- 03/07/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Ferro Corporation (NYSE:FOE) shares increased 4.11% to $6.84. A. Schulman Inc yesterday announced that it has made a proposal to the Board of Directors of Ferro Corp to acquire all of the outstanding shares of Ferro common stock for per-share consideration of $6.50, representing an estimated total enterprise value of approximately $855 million including total indebtedness. The offer represents a 25% premium over the closing price of Ferro common stock on March 1, 2013, and a 32% premium over the volume-weighted average trading price over the preceding 60-day period.

Additionally, FOE’s stock was downgraded by equities research analysts at Deutsche Bank to a “hold” rating in a research note issued to investors on Mar. 4.

How Should Investors Trade FOE After The Recent Price movement? Find out Here

Compania de Minas Buenaventura SA (ADR) (NYSE:BVN) shares increased 4.01% and closed at $24.44 in the last trading session. Golden Minerals Co last month announced the sale of exploration properties in Peru for approximately $4.8 million. The Company has entered into an agreement to sell the properties to Compania de Minas Buenaventura S.A.A. for $4.3 million, and has completed transactions for approximately $3.5 million of that amount. The sale of the remaining $0.8 million in exploration properties to Buenaventura is conditioned on the receipt of third party consents by February 28, 2013.

Is BVN a Strong Buying Opportunity After The Recent Slump? Find out Here

United States Steel Corporation (NYSE:X) shares jumped 3.85% and closed at $20.76 in the last trading session. X’s stock, on Mar. 4, has been reiterated by TheStreet Ratings as a sell with a ratings score of D+ . The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself.

Is X a Buy After The Latest Price Action? Find Out Here

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares jumped 3.71% and closed at $16.23 in the last trading session. The company, this week, announced the appointment of Edward Owens to its board of directors. Mr. Owens is a recently retired partner, portfolio manager and global industry analyst with Wellington Management Company, LLP. Mr. Owens started at Wellington in 1974 and served as portfolio manager for the Vanguard Health Care Fund from its inception in May 1984 until his retirement in December 2012.

Is IRWD a Buy After The Latest Price Action? Find Out Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.